Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease
Kidney International Jul 23, 2019
Faucon AL, et al. - In a prospective hospital-based cohort with chronic kidney disease (CKD) stage 1-4 (NephroTest Study), researchers assessed extracellular fluid (ECF) volume as a prognostic factor for CKD progression and mortality. They used the distribution volume and clearance of 51Cr-EDTA, respectively, to determine ECF (scaled to body surface area) and the measured glomerular filtration rate (mGFR). Overall 1593 patients were included with a mean age of 58.8 years. Men constituted 67% of the study sample. Mean mGFR and mean ECF was 43.6 mL/min/1.73m2 and 15.1 L/1.73m2, respectively. ECF was identified as an independent risk factor of CKD progression and death in this extensive cohort of carefully phenotyped CKD patients. For the clinical management of patients with non-dialysis CKD, the significance of close monitoring and treatment of fluid overload was underscored in this study.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries